Kwanan nan, Hukumar Kayayyakin Lafiya ta Ƙasa ta China (NMPA) ta amince da wani sabon magani na Bireocliclib, wani magani mai suna Aji 1 wanda Xuanzhu Biopharmaceutical ta ƙirƙiro shi daban-daban. Sabon maganin yana da nufin amfani da shi tare da maganin hana aromatase a matsayin maganin farko na endocrine ga marasa lafiya da ke fama da cutar kansar nono ta HR+/HER2. Wannan amincewa ta nuna Bireocliclib a matsayin magani na farko kuma tilo a cikin ajin ta a China da ya biya cikakken maganin cutar kansar nono ta HR+/HER2—gami da magungunan farko, na biyu, da na ƙarshe—wanda ke ba da sabon zaɓi na magani ga marasa lafiya a duk duniya.
Idan kai ko ƙaunatattunka kuna neman hanyoyin magance cutar kansar nono mafi kyau, da fatan za ku iya tuntuɓar Sashen Duniya na Asibitin Oncology na Yankin Kudu na Beijing:
- Waya: 400-880-3716
- WeChat: 17801183037
- Email ①: 100085_010@163.com
- Email ②: myimmnet@163.com
—
**Daga Layi na Biyu zuwa Layi na Farko: Cikakkiyar "Cikakkiyar Darasi" ta Bireocliclib**
Bireocliclib wani sabon maganin hana CDK2/4/6 ne. An amince da shi a baya don amfani da shi tare da fulvestrant don ciwon nono mai tsanani wanda ya ci gaba bayan maganin endocrine, da kuma maganin da aka yi wa marasa lafiya da ke fama da cutar rashin lafiya. Amincewar wannan sabon magani ya haɓaka amfani da shi zuwa maganin endocrine na farko, wanda ya cimma cikakken kariya daga magani na farko zuwa maganin ceto na gaba.
Wannan amincewar ta dogara ne akan sakamakon bincike na wucin gadi na binciken BRIGHT-3. Binciken ya nuna cewa matsakaicin rayuwa ba tare da ci gaba ba (PFS) ga ƙungiyar Bireocliclib plus AI har yanzu ba a cimma ba, wanda ke nuna ingantaccen tasiri mai ɗorewa; idan aka kwatanta, PFS na ƙungiyar kulawa ya kasance watanni 18.4. Abin da ya fi ƙarfafa gwiwa shi ne, ƙimar PFS na shekaru 2 a cikin ƙungiyar Bireocliclib ya wuce kashi 60%, kuma ƙimar amsawar manufa (ORR) ta kai kashi 63.5%, wanda ya haura zuwa kashi 67.6% a cikin marasa lafiya da raunuka masu aunawa. Waɗannan bayanai sun nuna cewa Bireocliclib a halin yanzu yana nuna mafi kyawun inganci tsakanin magunguna makamantan su.
**Ƙarin Zane Mai Kyau: Daidaita Daidaito da Tsaro Tsakanin Manufofi Da Dama**
Keɓancewar Bireocliclib ta ta'allaka ne da tsarin aiki mai haɗaka da dama. A matsayin sabon mai hana CDK2/4/6, ba wai kawai yana hana CDK4 da CDK6 ƙarfi ba, har ma yana hana CDK2 da CDK9 a lokaci guda.
- **Jinkirin Juriya ga Magunguna:** Kunna CDK2 yana ɗaya daga cikin mahimman hanyoyin juriya ga masu hana CDK4/6. Ta hanyar hana CDK2 a lokaci guda, Bireocliclib zai iya toshe hanyoyin yaduwar ƙwayoyin ƙari sosai, ta haka yana jinkirta fara juriya ga magunguna daga tushen.
- **Ƙarancin Guba:** Guba daga jini kamar su neutropenia na mataki na 3/4, wanda aka fi gani tare da magungunan hana CDK4/6 na gargajiya, ana rage shi sosai ta hanyar amfani da maganin Bireocliclib. Wannan yana nufin marasa lafiya za su iya samun ingantacciyar haƙuri a magani, ta hanyar rage katsewar magani saboda illolin da ke tattare da shi, ta haka ne za a tabbatar da ci gaba da inganci.
**Bayani Ya Tabbatar da Ƙarfi: Cikakken Nasarar Jerin Nazarin BRIGHT**
Kyakkyawan aikin Bireocliclib ba wani abu bane da aka saba gani, amma an gina shi ne akan harsashi mai ƙarfi na jerin binciken BRIGHT:
- **Nazarin BIRGIT-2 (Maganin Layi na Biyu):** Bireocliclib tare da fulvestrant ya cimma matsakaicin PFS na watanni 17.5. A cikin kwatancen da ba na kai-da-kai ba, wannan bayanin shine mafi kyau a cikin aji.
- **Nazarin BRIGHT-1 (Maganin Layi na Daga Baya):** Ga marasa lafiya da aka riga aka yi musu magani sosai, waɗanda suka yi fama da rashin ƙarfin gwiwa, maganin Bireocliclib monotherapy ya haifar da matsakaicin PFS na watanni 11 da matsakaicin rayuwa gabaɗaya (OS) na watanni 29. Wannan kuma shine mafi kyawun bayanai a duniya, yana tabbatar da ingancinsa ga mafi yawan marasa lafiya da ke fuskantar ƙalubale.
**Me Yasa Zabi Sashen Duniya na Asibitin Cutar Kanjamau na Yankin Kudu na Beijing?**
Sashen Duniya na Asibitin Oncology na Yankin Kudu na Beijing ya sadaukar da kai don haɗa sabbin dabarun magunguna na duniya tare da manyan albarkatun asibiti na China. A matsayin wani sabon magani da aka ƙirƙira a China, amincewar Bireocliclib ba wai kawai tana amfanar marasa lafiya na cikin gida ba ne, har ma tana ba da sabon fata ga marasa lafiya na ƙasashen waje. Sashenmu na Ƙasashen Duniya yana ba marasa lafiya na ƙasashen waje:
1. **Shawarwari da dama:** Kimanta yanayin lafiya da kuma haɓaka tsare-tsare na musamman ta hanyar ƙungiyar kwararru a fannin ciwon nono.
2. **Samun Magani Mai Kirkire-kirkire:** Samun damar amfani da sabbin magungunan hana ciwon daji na kasar Sin da aka amince da su a kan lokaci, ciki har da Bireocliclib.
3. **Cikakken Sabis na Tsari:** Tallafin likita na tsayawa ɗaya, tun daga fara shawarwari da aiwatar da shirin magani zuwa bin diddigin lokaci mai tsawo.
4. **Taimakon Harshe da Sufuri:** Fassarar likitanci ta ƙwararru da kuma isa ga marasa lafiya na ƙasashen waje don magance matsalolin kayan aiki.
**Tuntube Mu Yanzu**
Idan kai ko 'yan uwanka kuna fama da cutar kansar nono mai tsanani ta HR+/HER2 kuma kuna son sanin ko Bireocliclib zai iya zama magani mai dacewa, da fatan za a tuntuɓi Sashen Duniya na Asibitin Oncology na Yankin Kudu na Beijing nan da nan. Ƙungiyar ƙwararrunmu za ta ba ku cikakken shawarwari da taimako don neman kulawar lafiya a China.
- ��� Waya: 400-880-3716
- ��� WeChat: 17801183037
- ��� Email: 100085_010@163.com or myimmnet@163.com
Lokacin Saƙo: Maris-06-2026